Human Genome Epidemiology Literature Finder
Records 1 - 12 (of 12 Records) |
Query Trace: Thrombocytopenia and ABCG2[original query] |
---|
Impact of genetic variation in breast cancer resistance protein (BCRP/ABCG2) on sunitinib pharmacokinetics. Drug metabolism and pharmacokinetics 2012 27 (6): 631-9. Mizuno Tomoyuki, Fukudo Masahide, Terada Tomohiro, Kamba Tomomi, Nakamura Eijiro, Ogawa Osamu, Inui Ken-Ichi, Katsura Toshi |
Pharmacogenetic determinants associated with sunitinib-induced toxicity and ethnic difference in Korean metastatic renal cell carcinoma patients. Cancer chemotherapy and pharmacology 2013 Oct 72 (4): 825-35. Kim Hye Ryun, Park Hyung Soon, Kwon Woo Sun, Lee Ji Hyun, Tanigawara Yusuke, Lim Sun Min, Kim Hyo Song, Shin Sang Jun, Ahn Jung Bae, Rha Sun You |
Role of the lean body mass and of pharmacogenetic variants on the pharmacokinetics and pharmacodynamics of sunitinib in cancer patients. Investigational new drugs 2015 Feb 33 (1): 257-68. Narjoz C, Cessot A, Thomas-Schoemann A, Golmard J L, Huillard O, Boudou-Rouquette P, Behouche A, Taieb F, Durand J P, Dauphin A, Coriat R, Vidal M, Tod M, Alexandre J, Loriot M A, Goldwasser F, Blanchet |
Genetic variation in platinating agent and taxane pathway genes as predictors of outcome and toxicity in advanced non-small-cell lung cancer. Pharmacogenomics 2014 15 (12): 1565-74. Lamba Jatinder Kaur, Fridley Brooke L, Ghosh Taraswi M, Yu Qing, Mehta Gaurav, Gupta Pank |
A study to explore the correlation of ABCB1, ABCG2, OCT1 genetic polymorphisms and trough level concentration with imatinib mesylate-induced thrombocytopenia in chronic myeloid leukemia patients. Cancer chemotherapy and pharmacology 2015 Nov . Francis Jose, Dubashi Biswajit, Sundaram Rajan, Pradhan Suresh Chandra, Chandrasekaran Adith |
Polymorphisms in SLCO1B1 and UGT1A1 are associated with sorafenib-induced toxicity. Pharmacogenomics 2016 09 17 (14): 1483-90. Bins Sander, Lenting Anne, El Bouazzaoui Samira, van Doorn Leni, Oomen-de Hoop Esther, Eskens Ferry Alm, van Schaik Ron Hn, Mathijssen Ron |
Association Study of a Functional Variant on ABCG2 Gene with Sunitinib-Induced Severe Adverse Drug Reaction. PloS one 2016 11 (2): e0148177. Low Siew-Kee, Fukunaga Koya, Takahashi Atsushi, Matsuda Koichi, Hongo Fumiya, Nakanishi Hiroyuki, Kitamura Hiroshi, Inoue Takamitsu, Kato Yoichiro, Tomita Yoshihiko, Fukasawa Satoshi, Tanaka Tomoaki, Nishimura Kazuo, Uemura Hirotsugu, Hara Isao, Fujisawa Masato, Matsuyama Hideyasu, Hashine Katsuyoshi, Tatsugami Katsunori, Enokida Hideki, Kubo Michiaki, Miki Tsuneharu, Mushiroda Tais |
Characteristics of early-onset hematotoxicity of sunitinib in Japanese patients with renal cell carcinoma. BMC cancer 2017 Mar 17 (1): 214. Kato Renpei, Kato Yoichiro, Matsuura Tomohiko, Kanehira Mitsugu, Takata Ryo, Obara Wata |
Associations among regorafenib concentrations, severe adverse reactions, and ABCG2 and OATP1B1 polymorphisms. Cancer chemotherapy and pharmacology 2019 Jan 83 (1): 107-113. Maeda Akimitsu, Irie Kei, Ando Hitoshi, Hasegawa Ayako, Taniguchi Hiroya, Kadowaki Shigenori, Muro Kei, Tajika Masahiro, Aoki Masahiro, Inaguma Kazuhide, Kajita Masaki, Fujimura Akio, Fukushima Sho |
Meta-Analysis of ABCG2 and ABCB1 Polymorphisms With Sunitinib-Induced Toxicity and Efficacy in Renal Cell Carcinoma. Frontiers in pharmacology 2021 3 12 641075. Sun Fengjun, Chen Zhuo, Yao Pu, Weng Bangbi, Liu Zhirui, Cheng L |
Effects of ABCB1 and ABCG2 polymorphisms on the pharmacokinetics of abemaciclib. European journal of clinical pharmacology 2022 May . Maeda Akimitsu, Ando Hitoshi, Irie Kei, Hashimoto Naoya, Morishige Jun-Ichi, Fukushima Shoji, Okada Akira, Ebi Hiromichi, Matsuzaki Masahide, Iwata Hiroji, Sawaki Masata |
Irinotecan-Induced Toxicity: A Pharmacogenetic Study Beyond UGT1A1. Clinical pharmacokinetics 2023 9 . Mirjam de With, Leni van Doorn, Esmay Kloet, Anne van Veggel, Maja Matic, Micha J de Neijs, Esther Oomen-de Hoop, Esther van Meerten, Ron H N van Schaik, Ron H J Mathijssen, Sander Bi |
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 25, 2024
- Content source: